WO2004080272A3 - Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal - Google Patents

Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal Download PDF

Info

Publication number
WO2004080272A3
WO2004080272A3 PCT/FR2004/000572 FR2004000572W WO2004080272A3 WO 2004080272 A3 WO2004080272 A3 WO 2004080272A3 FR 2004000572 W FR2004000572 W FR 2004000572W WO 2004080272 A3 WO2004080272 A3 WO 2004080272A3
Authority
WO
WIPO (PCT)
Prior art keywords
genes
rgrp
leprotl1
diabetes
loss
Prior art date
Application number
PCT/FR2004/000572
Other languages
English (en)
Other versions
WO2004080272A2 (fr
Inventor
Bernard Bailleul
Yves Rouille
Karin Seron
Sandrine Belouzard
Original Assignee
Centre Nat Rech Scient
Bernard Bailleul
Yves Rouille
Karin Seron
Sandrine Belouzard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Bernard Bailleul, Yves Rouille, Karin Seron, Sandrine Belouzard filed Critical Centre Nat Rech Scient
Priority to CA002518761A priority Critical patent/CA2518761A1/fr
Priority to EP04718992A priority patent/EP1601973A2/fr
Publication of WO2004080272A2 publication Critical patent/WO2004080272A2/fr
Publication of WO2004080272A3 publication Critical patent/WO2004080272A3/fr
Priority to US11/221,275 priority patent/US20060068429A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une méthode d'identification de composés actifs sur la perte ou la prise de poids ou le diabète chez un sujet humain ou animal, caractérisé en ce que l'on mesure l'effet dudit composé sur (a) l'expression de l'un au moins des gènes LEPROTL1 et OB­ RGRP ou partie de ceux-ci, et/ou (b) le transport intracellulaire jusqu'à la membrane cellulaire, et/ou (c) la présence au niveau de la membrane cellulaire, et/ou (d) l'internalisation depuis la membrane, des protéines codées par l'un au moins desdits gènes ou partie de ceux-ci.
PCT/FR2004/000572 2003-03-10 2004-03-10 Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal WO2004080272A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002518761A CA2518761A1 (fr) 2003-03-10 2004-03-10 Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal
EP04718992A EP1601973A2 (fr) 2003-03-10 2004-03-10 Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d un sujet humain ou animal
US11/221,275 US20060068429A1 (en) 2003-03-10 2005-09-07 LEPROTL1 and OB-RGRP genes for screening compounds that act on the gain or loss of weight or on diabetes in a human or animal subject

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302931A FR2852397B1 (fr) 2003-03-10 2003-03-10 Utilisation des genes leprotl 1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal.
FR03/02931 2003-03-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/221,275 Continuation US20060068429A1 (en) 2003-03-10 2005-09-07 LEPROTL1 and OB-RGRP genes for screening compounds that act on the gain or loss of weight or on diabetes in a human or animal subject

Publications (2)

Publication Number Publication Date
WO2004080272A2 WO2004080272A2 (fr) 2004-09-23
WO2004080272A3 true WO2004080272A3 (fr) 2004-11-04

Family

ID=32893169

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/000572 WO2004080272A2 (fr) 2003-03-10 2004-03-10 Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal

Country Status (5)

Country Link
US (1) US20060068429A1 (fr)
EP (1) EP1601973A2 (fr)
CA (1) CA2518761A1 (fr)
FR (1) FR2852397B1 (fr)
WO (1) WO2004080272A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070050237A1 (en) * 2005-08-30 2007-03-01 Microsoft Corporation Visual designer for multi-dimensional business logic
AU2017359439A1 (en) 2016-11-08 2019-05-23 Regeneron Pharmaceuticals, Inc. Antigen-binding proteins that antagonize leptin receptor
BR112020012011A2 (pt) 2017-12-18 2020-11-24 Regeneron Pharmaceuticals, Inc. moléculas de ligação a antígeno biespecífica isolada e de ligação a antígeno biespecífica ou cadeia de imunoglobulina, composição farmacêutica, recipiente ou dispositivo de injeção, ácido nucleico isolado, vetor isolado, célula hospedeira isolada, métodos para tratar uma doença ou condição, para tratar uma condição de lipodistrofia em um sujeito, para produzir uma molécula de ligação a antígeno biespecífica, e, para administrar uma molécula de ligação a antígeno biespecífica isolada ou composição farmacêutica.
AU2019249273A1 (en) 2018-04-06 2020-10-15 Regeneron Pharmaceuticals, Inc. Methods of treatment using a leptin receptor agonist antibody

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BAILLEUL B ET AL: "THE LEPTIN RECEPTOR PROMOTER CONTROLS EXPRESSION OF A SECOND DISTINCT PROTEIN", 1997, NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, VOL. 25, NR. 14, PAGE(S) 2752-2758, ISSN: 0305-1048, XP002050420 *
HUANG Y ET AL: "Cloning and characterization of a novel human leptin receptor overlapping transcript-like 1 gene (LEPROTL1)", 2001, BIOCHIMICA ET BIOPHYSICA ACTA. GENE STRUCTURE AND EXPRESSION, ELSEVIER, AMSTERDAM, NL, VOL. 1517, NR. 2, PAGE(S) 327-331, ISSN: 0167-4781, XP004248823 *
SERON K ET AL: "OB-RGRP AND LEPROTL1 DEFINE A NEW FAMILY OF LIPID RAFT-ASSOCIATED TETRASPANNING MEMBRANE PROTEINS LOCALIZED AT THE TGN AND/OR ENDOSOMES", 2001, BIOLOGY OF THE CELL, VOL. 93, PAGE 227, 2001, XP001154434 *

Also Published As

Publication number Publication date
US20060068429A1 (en) 2006-03-30
CA2518761A1 (fr) 2004-09-23
EP1601973A2 (fr) 2005-12-07
FR2852397B1 (fr) 2005-04-29
FR2852397A1 (fr) 2004-09-17
WO2004080272A2 (fr) 2004-09-23

Similar Documents

Publication Publication Date Title
MX337782B (es) Combinaciones de productos activos.
WO2008064778A3 (fr) Combinaisons d'agents actifs insecticides (formononétine + insecticides)
EG25314A (en) Insecticide for agricultural or horticultural use and method of use thereof.
MX2007000392A (es) Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas.
WO2003018636A3 (fr) Compositions et procedes pour traiter le diabete
CR20130636A (es) Combinaciones de productos activos con propiedades namaticidas e insecticidas, basadas en compuestos de trifluorbutenilo
WO2004060052A3 (fr) Souris transgeniques exprimant le cd20 et/ou le cd16 humain(s)
AP2006003568A0 (en) 2-cyanobenzenesulfonamides for combating animal pests.
MX2008002802A (es) Secuencias nucleotidicas que codifican proteinas insecticidas.
WO2008080542A3 (fr) Produit de combinaison destiné à la lutte contre les parasites chez l'animal
ECSP056139A (es) Combinaciones de productos activos con propiedades nematicidas, insecticidas y fungicidas, basadas en compuestos de trifluorbutenilo
MX275245B (es) Composicion de acaros, uso de la misma, metodo para criar un acaro predatorio phytoseiid, sistema de crianza para criar dicho acaro predatorio phytoseiid y metodos para el control biologico de plagas en un cultivo.
MXPA05011835A (es) Agentes para combatir parasitos en animales.
WO2005053393A3 (fr) Combinaisons d'agents comprenant des proprietes insecticides
WO2007006591A3 (fr) Dihalogenation d'hydroxipyridones n,o-disubstituees et leurs utilisations
WO2005096819A3 (fr) Combinaisons de principes actifs a proprietes insecticides
TW200513256A (en) Antifungal and/or antimycotic external preparation for nail
WO2007065576A3 (fr) Association fongicide de principes actifs
WO2004080272A3 (fr) Utilisation des genes leprotl1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal
EP1376359A3 (fr) Traitement des informations de configuration pour dispositifs de stockage réseau
UA90367C2 (ru) Зерна зерновых культур, обработанные водной композицией родентицида, способ приготовления композиции для приманки и способ борьбы с грызунами
NO20064729L (no) Parasitticidale midler
CU23309B7 (es) Compuestos anã logos de astrobilurinas y su uso como acaricida e insecticida
WO2002023985A3 (fr) Combinaisons de principes actifs servant a proteger des peaux d'animaux et le cuir
AU2003249853A8 (en) Genetically engineered keratinocytes expressing at least one growth factor and/or activated egf receptor, skin equivalent comprising said keratinocytes and toxicity assay using said keratinocytes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11221275

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004718992

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2518761

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2004718992

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11221275

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2004718992

Country of ref document: EP